As the leading organization focused on finding cures for Crohn's disease and ulcerative colitis, IBD prevention is a key focus for the Crohn's & Colitis Foundation. Our Chief Scientific Officer, Alan Moss, MD, will present on "Prevention of IBD: Are We Ready?" at the 17th Annual Inflammatory Bowel Disease: The Art and Science in the Diagnosis and Treatment 2024 conference at Boston University Chobanian & Avedisian School of Medicine. This event brings together top gastroenterology specialists to discuss cutting-edge developments in IBD care: https://bit.ly/4d16qHz
Crohn's & Colitis Foundation的动态
最相关的动态
-
Congratulations to Erin McKeon, Associate Director of Federal Advocacy at Crohn’s & Colitis Foundation, on winning the Biosimilars Champion award from the Biosimilars Forum! The award was recently presented to five alliance champions for their work and dedication to increasing access to lower-cost biosimilars for patients.
The Biosimilars Forum recently presented the Biosimilars Champion award to five alliance champions for their work and dedication to increasing access to lower-cost biosimilars for patients. The five awardees are: Pam Traxel, Senior Vice President for Alliance Development and Philanthropy at American Cancer Society Cancer Action Network Anna Hyde, Vice President of Advocacy & Access at Arthritis Foundation Erin McKeon, Associate Director of Federal Advocacy at Crohn’s & Colitis Foundation Robin Strongin, Director of Public Policy at National Consumers League Jason Harris, Vice President of Government Relations & Advocacy at National Psoriasis Foundation The Biosimilars Champion award is given to industry innovators, legislative champions, and patient/patient group leaders who have gone above and beyond to further the promise of biosimilars. Thank you to our champions for their work with the Forum and through their own organizations to ensure all patients have access to these lower-cost treatment options.
-
-
The Crohn's & Colitis Foundation has released its groundbreaking five-year research priorities, focusing on critical areas like IBD biology, environmental triggers, and personalized treatments. This collaborative effort, involving researchers, healthcare providers, and patients, aims to drive innovation and improve the lives of those with IBD. Discover the full research agenda and what it means to patients in our Summer 2024 Impact Report: https://bit.ly/4cJwyGP
-
-
Whether you or your loved one is diagnosed with IBD at a young age or later in life, IBD is a lifelong disease and long-term management is essential for a high quality of life. Join us for an insightful and empowering discussion on thriving with long-term IBD to understand evolving needs as you age. Register now: https://bit.ly/3T8prRj
-
-
We’re excited to announce our partnership with @drinkwholesome! ?? From now until September 11, 10% of all website sales of egg white, collagen, and almond-based protein powders and meal replacements will go directly to the Crohn’s & Colitis Foundation. This generous contribution will support our mission to advance research and enhance the quality of life for those living with Crohn’s disease and ulcerative colitis. Explore their offerings: https://lnkd.in/gzq7fzbn #sponsored
-
-
???? Are you a streamer or a gamer ready to level up for a great cause? You can stream, fundraise, and make an impact on the IBD community by hosting a charity stream event! Join us: https://bit.ly/3P5tP1M
-
-
September is Women in Medicine Month, and we would like to thank our three amazing Co-Chairs for Crohn’s & Colitis Congress: Christina Ha, MD (Mayo Clinic), Jessica Allegretti, MD, MPH (Brigham and Women's Hospital), and Karen Edelblum, PhD, Icahn School of Medicine at Mount Sinai. Thank you for all that you do for patients and for leading the way to a new and inventive Congress.
-
